Shang Li

Search results

• 2019

  CheckMate 817: First-Line Nivolumab plus Ipilimumab in Patients with ECOG PS 2 and Other Special Populations with Advanced NSCLC

  Barlesi, F., Audigier-Valette, C., Felip, E., Ciuleanu, T., Jao, K., Rijavec, E., Urban, L., Aucoin, J., Zannori, C., Vermaelen, K., Frontera, O. A., Ready, N., Fontecedro, A. C., Linardou, H., Poddubskaya, E., Fischer, J., Iordan, I., Groen, H., Pillai, R. & Li, S. & 4 others, Fiore, J., Chang, H., Acevedo, A. & Paz-Ares, L., Oct-2019, In: Journal of Thoracic Oncology. 14, 10, p. S214-S215 2 p.

  Research output: Contribution to journal › Meeting Abstract › Academic